• Tue news: Merck's Keytruda stages comeback in head and neck cancer. GSK, Pfizer RSV vaccine sales fall. Astellas gene therapy bet. Extreme weather —>drug shortages. J&J discontinues bladder cancer drug. See more on our front page

AstraZeneca

Anonymous board for AstraZeneca.
Replies
26
Views
8K
anonymous
Replies
2
Views
510
anonymous
Replies
12
Views
2K
Woody Woodworth
Replies
41
Views
5K
anonymous
Replies
14
Views
5K
anonymous
Replies
39
Views
10K
anonymous
Replies
131
Views
11K
anonymous
Replies
7
Views
2K
anonymous
Replies
2K
Views
180K
anonymous
Replies
11
Views
2K
anonymous
Replies
4
Views
1K
anonymous
Replies
15
Views
5K
anonymous
Replies
2
Views
565
anonymous
Replies
40
Views
12K
anonymous
Replies
81
Views
19K
anonymous
Replies
1
Views
421
anonymous
Replies
1
Views
765
anonymous